← k3vl4r
Log inGet started →

PFE (Pfizer) Price Forecast

AI-generated price forecast for Pfizer (PFE) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads PFE as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 27.81. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

27.81

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

PFE forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▼ Down-13.12%—
Weekly~1.7 years out———

Congressional trades in PFE

Public STOCK Act disclosures · amounts are ranges, reported up to ~45 days after the trade.

MemberActionDateAmount
Thomas H Tuberville (joint)▼ Sell2026-06-08$15001–50000
Alan Armstrong▼ Sell2026-03-24$50001–100000
James French Hill▼ Sell2025-12-31$100001–250000

Track what Congress is trading across the whole market in the app — get started free.

Latest PFE news

From the market-news feed the forecasts are read against.

  • Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? · Yahoo · Oct 4
  • Here's Exactly Why I'm Not Afraid of Pfizer's 6% Dividend Yield · Yahoo · Oct 4
  • 5 High-Yield Dividend Stocks to Buy for October Income with Cash Flow to Spare · ldr:247wallst.com · Oct 3
  • Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? · Yahoo · Oct 2
  • Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026 | CATX Stock News · ldr:stocktitan.net · Oct 2

🔒

See the full PFE forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

PFE forecast — frequently asked

Will PFE go up?

K3vl4r's AI model currently reads PFE as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the PFE price prediction for 2026?

K3vl4r's model projects PFE toward $27.76 over the next ~3 months, a -0.1% move from $27.80. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

NVOJNJBMYSNYLLYRPRXPCRXPRGONVSABBVAZNTEVAHRMYMRK

Will PFE reach…?

Will PFE reach $50.00?Will PFE reach $100.00?Will PFE reach $200.00?

Or see the full PFE price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare PFE

PFE vs NVOPFE vs JNJPFE vs BMYPFE vs SNYPFE vs LLYPFE vs RPRX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.